Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker

Abstract Despite efforts to improve tuberculosis (TB) detection, limitations in access, quality and timeliness of diagnostic services in low- and middle-income countries are challenging for current TB diagnostics. This study aimed to identify and characterise a metabolic profile of TB in urine by hi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: José Luis Izquierdo-Garcia, Patricia Comella-del-Barrio, Ramón Campos-Olivas, Raquel Villar-Hernández, Cristina Prat-Aymerich, Maria Luiza De Souza-Galvão, Maria Angeles Jiménez-Fuentes, Juan Ruiz-Manzano, Zoran Stojanovic, Adela González, Mar Serra-Vidal, Esther García-García, Beatriz Muriel-Moreno, Joan Pau Millet, Israel Molina-Pinargote, Xavier Casas, Javier Santiago, Fina Sabriá, Carmen Martos, Christian Herzmann, Jesús Ruiz-Cabello, José Domínguez
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c0ec83e3132d44ef9288c211956549d3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c0ec83e3132d44ef9288c211956549d3
record_format dspace
spelling oai:doaj.org-article:c0ec83e3132d44ef9288c211956549d32021-12-02T12:40:40ZDiscovery and validation of an NMR-based metabolomic profile in urine as TB biomarker10.1038/s41598-020-78999-42045-2322https://doaj.org/article/c0ec83e3132d44ef9288c211956549d32020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-78999-4https://doaj.org/toc/2045-2322Abstract Despite efforts to improve tuberculosis (TB) detection, limitations in access, quality and timeliness of diagnostic services in low- and middle-income countries are challenging for current TB diagnostics. This study aimed to identify and characterise a metabolic profile of TB in urine by high-field nuclear magnetic resonance (NMR) spectrometry and assess whether the TB metabolic profile is also detected by a low-field benchtop NMR spectrometer. We included 189 patients with tuberculosis, 42 patients with pneumococcal pneumonia, 61 individuals infected with latent tuberculosis and 40 uninfected individuals. We acquired the urine spectra from high and low-field NMR. We characterised a TB metabolic fingerprint from the Principal Component Analysis. We developed a classification model from the Partial Least Squares-Discriminant Analysis and evaluated its performance. We identified a metabolic fingerprint of 31 chemical shift regions assigned to eight metabolites (aminoadipic acid, citrate, creatine, creatinine, glucose, mannitol, phenylalanine, and hippurate). The model developed using low-field NMR urine spectra correctly classified 87.32%, 85.21% and 100% of the TB patients compared to pneumococcal pneumonia patients, LTBI and uninfected individuals, respectively. The model validation correctly classified 84.10% of the TB patients. We have identified and characterised a metabolic profile of TB in urine from a high-field NMR spectrometer and have also detected it using a low-field benchtop NMR spectrometer. The models developed from the metabolic profile of TB identified by both NMR technologies were able to discriminate TB patients from the rest of the study groups and the results were not influenced by anti-TB treatment or TB location. This provides a new approach in the search for possible biomarkers for the diagnosis of TB.José Luis Izquierdo-GarciaPatricia Comella-del-BarrioRamón Campos-OlivasRaquel Villar-HernándezCristina Prat-AymerichMaria Luiza De Souza-GalvãoMaria Angeles Jiménez-FuentesJuan Ruiz-ManzanoZoran StojanovicAdela GonzálezMar Serra-VidalEsther García-GarcíaBeatriz Muriel-MorenoJoan Pau MilletIsrael Molina-PinargoteXavier CasasJavier SantiagoFina SabriáCarmen MartosChristian HerzmannJesús Ruiz-CabelloJosé DomínguezNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
José Luis Izquierdo-Garcia
Patricia Comella-del-Barrio
Ramón Campos-Olivas
Raquel Villar-Hernández
Cristina Prat-Aymerich
Maria Luiza De Souza-Galvão
Maria Angeles Jiménez-Fuentes
Juan Ruiz-Manzano
Zoran Stojanovic
Adela González
Mar Serra-Vidal
Esther García-García
Beatriz Muriel-Moreno
Joan Pau Millet
Israel Molina-Pinargote
Xavier Casas
Javier Santiago
Fina Sabriá
Carmen Martos
Christian Herzmann
Jesús Ruiz-Cabello
José Domínguez
Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker
description Abstract Despite efforts to improve tuberculosis (TB) detection, limitations in access, quality and timeliness of diagnostic services in low- and middle-income countries are challenging for current TB diagnostics. This study aimed to identify and characterise a metabolic profile of TB in urine by high-field nuclear magnetic resonance (NMR) spectrometry and assess whether the TB metabolic profile is also detected by a low-field benchtop NMR spectrometer. We included 189 patients with tuberculosis, 42 patients with pneumococcal pneumonia, 61 individuals infected with latent tuberculosis and 40 uninfected individuals. We acquired the urine spectra from high and low-field NMR. We characterised a TB metabolic fingerprint from the Principal Component Analysis. We developed a classification model from the Partial Least Squares-Discriminant Analysis and evaluated its performance. We identified a metabolic fingerprint of 31 chemical shift regions assigned to eight metabolites (aminoadipic acid, citrate, creatine, creatinine, glucose, mannitol, phenylalanine, and hippurate). The model developed using low-field NMR urine spectra correctly classified 87.32%, 85.21% and 100% of the TB patients compared to pneumococcal pneumonia patients, LTBI and uninfected individuals, respectively. The model validation correctly classified 84.10% of the TB patients. We have identified and characterised a metabolic profile of TB in urine from a high-field NMR spectrometer and have also detected it using a low-field benchtop NMR spectrometer. The models developed from the metabolic profile of TB identified by both NMR technologies were able to discriminate TB patients from the rest of the study groups and the results were not influenced by anti-TB treatment or TB location. This provides a new approach in the search for possible biomarkers for the diagnosis of TB.
format article
author José Luis Izquierdo-Garcia
Patricia Comella-del-Barrio
Ramón Campos-Olivas
Raquel Villar-Hernández
Cristina Prat-Aymerich
Maria Luiza De Souza-Galvão
Maria Angeles Jiménez-Fuentes
Juan Ruiz-Manzano
Zoran Stojanovic
Adela González
Mar Serra-Vidal
Esther García-García
Beatriz Muriel-Moreno
Joan Pau Millet
Israel Molina-Pinargote
Xavier Casas
Javier Santiago
Fina Sabriá
Carmen Martos
Christian Herzmann
Jesús Ruiz-Cabello
José Domínguez
author_facet José Luis Izquierdo-Garcia
Patricia Comella-del-Barrio
Ramón Campos-Olivas
Raquel Villar-Hernández
Cristina Prat-Aymerich
Maria Luiza De Souza-Galvão
Maria Angeles Jiménez-Fuentes
Juan Ruiz-Manzano
Zoran Stojanovic
Adela González
Mar Serra-Vidal
Esther García-García
Beatriz Muriel-Moreno
Joan Pau Millet
Israel Molina-Pinargote
Xavier Casas
Javier Santiago
Fina Sabriá
Carmen Martos
Christian Herzmann
Jesús Ruiz-Cabello
José Domínguez
author_sort José Luis Izquierdo-Garcia
title Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker
title_short Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker
title_full Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker
title_fullStr Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker
title_full_unstemmed Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker
title_sort discovery and validation of an nmr-based metabolomic profile in urine as tb biomarker
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/c0ec83e3132d44ef9288c211956549d3
work_keys_str_mv AT joseluisizquierdogarcia discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT patriciacomelladelbarrio discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT ramoncamposolivas discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT raquelvillarhernandez discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT cristinaprataymerich discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT marialuizadesouzagalvao discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT mariaangelesjimenezfuentes discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT juanruizmanzano discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT zoranstojanovic discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT adelagonzalez discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT marserravidal discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT esthergarciagarcia discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT beatrizmurielmoreno discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT joanpaumillet discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT israelmolinapinargote discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT xaviercasas discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT javiersantiago discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT finasabria discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT carmenmartos discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT christianherzmann discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT jesusruizcabello discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
AT josedominguez discoveryandvalidationofannmrbasedmetabolomicprofileinurineastbbiomarker
_version_ 1718393765489541120